{"text_format":"3","workbook":"xls","n_sheets":2,"sheets":["删减版","原文件"],"not_rendered":{"external_links":1,"defined_names":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"删减版","index":0,"n_rows":121,"n_cols":10,"rows_kept":121,"merged":[[0,0,0,9]],"flags":["formulas_cached_only"]}
["不符合挂网条件药品表"]
["目录名称","产品名称","规格","转换比","最小包装单位","生产企业","投标企业","报价","质量层次","不符合原因"]
["国采第一批同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","75mg(按C₁₆H₁₆ClNO₂S计)",14,"盒","北京四环制药有限公司,新华制药(高密)有限公司","山东新华制药股份有限公司",28.56,"过评","超同组最低价"]
["国采第一批同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","75mg(按C₁₆H₁₆ClNO₂S计)",28,"盒","北京四环制药有限公司,新华制药(高密)有限公司","山东新华制药股份有限公司",55.69,"过评","超同组最低价"]
["国采第一批同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","75mg(按C₁₆H₁₆ClNO₂S计)",28,"盒","国药集团致君(深圳)坪山制药有限公司","国药集团致君(深圳)制药有限公司",35.14,"过评","超同组最低价"]
["国采第一批同通用名(2025年10月份)-集采剂型-不限","恩替卡韦片","0.5mg",30,"盒","郑州泰丰制药有限公司","佑华医药科技有限公司",8.16,"过评","超同组最低价"]
["国采第一批同通用名(2025年10月份)-集采剂型-不限","孟鲁司特钠片","10mg(按C₃₅H₃₆ClNO₃S计)",10,"盒","浙江诺得药业有限公司","浙江诺得药业有限公司",24.98,"过评","超同组最低价"]
["国采第一批同通用名(2025年10月份)-集采剂型-不限","孟鲁司特钠片","10mg(按C₃₅H₃₆ClNO₃S计)",30,"盒","浙江诺得药业有限公司","浙江诺得药业有限公司",71.99,"过评","超同组最低价"]
["国采第二批同通用名(2025年10月份)-集采剂型-不限","盐酸曲美他嗪缓释片","35mg",30,"盒","郑州泰丰制药有限公司","佑华医药科技有限公司",13.74,"过评","超同组最低价"]
["国采第二批同通用名(2025年10月份)-集采剂型-不限","阿奇霉素片","500mg",3,"盒","Pliva Croatia Ltd.","海南华蓝医药健康产业有限公司",68,"原研/参比","超原研"]
["国采第二批同通用名(2025年10月份)-集采剂型-不限","甲硝唑片","0.2g",100,"瓶","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司",7.1,"过评","超同组最低价"]
["国采第三批同通用名(2025年10月份)-集采剂型-不限","碳酸氢钠片","0.5g",100,"瓶","安徽永生堂药业有限责任公司","安徽永生堂药业有限责任公司",8,null,"超同组最低价"]
["国采第三批同通用名(2025年10月份)-集采剂型-不限","阿哌沙班片","2.5mg",20,"盒","迪沙药业集团有限公司","迪沙药业集团有限公司",43.38,"过评","超同组最低价"]
["国采第三批同通用名(2025年10月份)-集采剂型-不限","盐酸莫西沙星氯化钠注射液","250ml∶盐酸莫西沙星(按C₂₁H₂₄FN₃O₄计)0.4g与氯化钠2.0g",1,"盒","东莞市普济药业有限公司","安徽康融药业有限公司",28,"过评","超同组最低价"]
["国采第三批同通用名(2025年10月份)-集采剂型-不限","非布司他片","20mg",14,"盒","华益药业科技(安徽)有限公司","昆明龙津药业股份有限公司",35.8,"过评","超同组最低价"]
["国采第三批同通用名(2025年10月份)-集采剂型-不限","非布司他片","40mg",14,"盒","华益药业科技(安徽)有限公司","昆明龙津药业股份有限公司",63,"过评","超同组最低价"]
["国采第三批同通用名(2025年10月份)-集采剂型-不限","盐酸左氧氟沙星滴眼液","0.3%(按C18H20FN3O4计),5ml/支",1,"盒","长春迪瑞制药有限公司","长春迪瑞制药有限公司",3.63,null,"超过评"]
["国采第四批同通用名(2025年10月份)-集采剂型-不限","艾司奥美拉唑镁肠溶胶囊","20mg(按C₁₇H₁₉N₃O₃S计)",30,"盒","江苏中邦制药有限公司","江苏中邦制药有限公司",108,"过评","超同组最低价"]
["国采第四批同通用名(2025年10月份)-集采剂型-不限","艾司奥美拉唑镁肠溶胶囊","40mg(按C₁₇H₁₉N₃O₃S计)",30,"盒","江苏中邦制药有限公司","江苏中邦制药有限公司",183.6,"过评","超同组最低价"]
["国采第四批同通用名(2025年10月份)-集采剂型-不限","缬沙坦氨氯地平片(Ⅰ)","每片含缬沙坦80mg,氨氯地平5mg",7,"盒","湖北午时药业股份有限公司","湖北午时药业股份有限公司",27.02,"过评","超同组最低价"]
["国采第四批同通用名(2025年10月份)-集采剂型-不限","甲磺酸左氧氟沙星片","0.1g",12,"盒","湖北午时药业股份有限公司","湖北午时药业股份有限公司",6.8,null,"超过评"]
["国采第四批同通用名(2025年10月份)-集采剂型-不限","普瑞巴林胶囊","75mg",8,"盒","浙江昂利康制药股份有限公司","浙江昂利康制药股份有限公司",18.88,"过评","超同组最低价"]
["国采第四批同通用名(2025年10月份)-集采剂型-不限","盐酸奥洛他定滴眼液","0.2%(2.5ml:5mg,按C₂₁H₂₃NO₃计)",1,"盒","深圳万和制药有限公司","深圳万和制药有限公司",62.8,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用艾司奥美拉唑钠","40mg(按C₁₇H₁₉N₃O₃S计)",1,"瓶","齐鲁制药(海南)有限公司","齐鲁制药有限公司",3.59,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用头孢呋辛钠","1.5g",1,"瓶","浙江惠迪森药业有限公司","浙江惠迪森药业有限公司",13.46,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用头孢呋辛钠","0.75g",1,"瓶","浙江惠迪森药业有限公司","浙江惠迪森药业有限公司",7.92,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用头孢他啶","1.0g(按C22H22N6O7S2计算)",1,"盒","海口奇力制药股份有限公司","海口奇力制药股份有限公司",8.37,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","左氧氟沙星注射液","20ml:500mg",1,"支","山东罗欣药业集团股份有限公司","国仁健康制药(北京)有限公司",27.3,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","左氧氟沙星氯化钠注射液","100ml:左氧氟沙星(按C₁₈H₂₀FN₃O₄计)0.5g与氯化钠0.9g",1,"袋","广东大翔制药有限公司","广东大翔制药有限公司",9.9,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用盐酸苯达莫司汀","100mg(按C₁₆H₂₁Cl₂N₃O₂•HCl计)",1,"盒","深圳万乐药业有限公司","深圳万乐药业有限公司",1080,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","阿立哌唑片","5mg",28,"盒","重庆药友制药有限责任公司","湖南洞庭药业股份有限公司",44.34,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","吸入用异丙托溴铵溶液","2ml:0.5mg(按C₂₀H₃₀BrNO₃计)",5,"盒","山东华鲁制药有限公司","佑华医药科技有限公司",18.4,"过评","超同组最低价"]
["国采第五批同通用名(2025年10月份)-集采剂型-不限","盐酸莫西沙星滴眼液","0.5%(0.4ml:2mg,按C₂₁H₂₄FN₃O₄计)",5,"盒","石家庄格瑞药业有限公司","石家庄格瑞药业有限公司",13.5,"过评","超同组最低价"]
["国采第七批同通用名(2025年10月份)-集采剂型-不限","盐酸利多卡因注射液","5ml:0.1g",1,"支","湖北津药药业股份有限公司","湖北津药药业股份有限公司",3.82,"过评","超同组最低价"]
["国采第七批同通用名(2025年10月份)-集采剂型-不限","依折麦布片","10mg",10,"盒","昆明龙津药业股份有限公司","云南龙津康佑生物医药有限公司",26.2,"过评","超同组最低价"]
["国采第七批同通用名(2025年10月份)-集采剂型-不限","注射用头孢米诺钠","0.5g",1,"瓶","安徽省先锋制药有限公司","安徽省先锋制药有限公司",15.95,"过评","超同组最低价"]
["国采第七批同通用名(2025年10月份)-集采剂型-不限","注射用头孢米诺钠","1.0g",1,"瓶","安徽省先锋制药有限公司","安徽省先锋制药有限公司",27.11,"过评","超同组最低价"]
["国采第七批同通用名(2025年10月份)-集采剂型-不限","拉考沙胺片","50mg",56,"盒","上海理想制药有限公司","上海理想制药有限公司",152.76,"过评","超同组最低价"]
["国采第七批同通用名(2025年10月份)-集采剂型-不限","拉考沙胺片","100mg",56,"盒","上海理想制药有限公司","上海理想制药有限公司",259.69,"过评","超同组最低价"]
["国采第七批同通用名(2025年10月份)-集采剂型-不限","盐酸鲁拉西酮片","按C₂₈H₃₆N₄O₂S·HCl计:40mg",30,"瓶","重庆药友制药有限责任公司","重庆药友制药有限责任公司",117,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","氨氯地平阿托伐他汀钙片","5mg/10mg(以氨氯地平/阿托伐他汀计)",15,"盒","湖南威特制药股份有限公司","湖南威特制药股份有限公司",37.65,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用哌拉西林钠他唑巴坦钠","1.125g(含哌拉西林1.0g,他唑巴坦0.125g)",1,"瓶","海口奇力制药股份有限公司","海口奇力制药股份有限公司",6.43,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用哌拉西林钠他唑巴坦钠","2.25g(含哌拉西林2.0g,他唑巴坦0.25g)",1,"瓶","海口奇力制药股份有限公司","海口奇力制药股份有限公司",10.93,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用哌拉西林钠他唑巴坦钠","4.5g(含哌拉西林4.0g,他唑巴坦0.5g)",1,"盒","海口奇力制药股份有限公司","海口奇力制药股份有限公司",18.58,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","头孢地尼颗粒","50mg",6,"盒","四川合信药业有限责任公司","重庆吉斯瑞制药有限责任公司",60,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用比阿培南","0.3g",1,"盒","山东罗欣药业集团股份有限公司","江苏睿实生物科技有限公司",72,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","甲硝唑氯化钠注射液","100ml:甲硝唑0.5g与氯化钠0.74g",1,"袋","广东大翔制药有限公司","广东大翔制药有限公司",5.78,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","磷酸奥司他韦干混悬剂","0.36g(按C₁₆H₂₈N₂O₄计)",1,"盒","山西同达药业有限公司","山西同达药业有限公司",59,"过评","超同组最低价"]
["国采第八批同通用名(2025年10月份)-集采剂型-不限","磷酸奥司他韦干混悬剂","0.36g(按C₁₆H₂₈N₂O₄计)",2,"盒","山西同达药业有限公司","山西同达药业有限公司",118,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","奥美拉唑碳酸氢钠胶囊(Ⅱ)","每粒含奥美拉唑40mg与碳酸氢钠1100mg",30,"瓶","厦门恩成制药有限公司","厦门恩成制药有限公司",34.01,null,"超过评"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","葡萄糖酸钙氯化钠注射液","100ml:葡萄糖酸钙1g与氯化钠0.8g",1,"袋","石家庄四药有限公司","石家庄四药有限公司",5.62,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","硫酸镁注射液","100ml:4g",1,"袋","山东华鲁制药有限公司","北京柏雅联合药物研究所有限公司",66,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","奥美沙坦酯氨氯地平片","每片含奥美沙坦酯20mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)",8,"盒","昆明龙津药业股份有限公司","云南龙津康佑生物医药有限公司",9.91,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","枸橼酸西地那非口崩片","50mg(按C₂₂H₃₀N₆O₄S计)",2,"盒","昆明龙津药业股份有限公司","云南龙津康佑生物医药有限公司",36,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","阿立哌唑口服溶液","50ml:50mg",1,"盒","浙江北生药业汉生制药有限公司","西洲医药科技(浙江)有限公司",82,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","地夸磷索钠滴眼液","3%(5ml:150mg)",1,"盒","深圳万和制药有限公司","深圳万和制药有限公司",56.3,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","地夸磷索钠滴眼液","3%(5ml:150mg)",1,"盒","石家庄格瑞药业有限公司","石家庄格瑞药业有限公司",49.3,"过评","超同组最低价"]
["国采第九批同通用名(2025年10月份)-集采剂型-不限","地夸磷索钠滴眼液","3%(0.4ml:12mg)",10,"盒","石家庄格瑞药业有限公司","石家庄格瑞药业有限公司",71.31,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用盐酸罗沙替丁醋酸酯","75mg",1,"支","湖北午时药业股份有限公司","湖北午时药业股份有限公司",145,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","西格列汀二甲双胍片(Ⅱ)","每片含磷酸西格列汀50mg(以C₁₆H₁₅F₆N₅O计)和盐酸二甲双胍850mg(以C₄H₁₁N₅•HCl计)",14,"盒","浙江永太药业有限公司","浙江永太药业有限公司",47.6,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","阿司匹林肠溶片","25mg",100,"瓶","平光制药股份有限公司,江苏平光制药有限责任公司","江苏平光制药有限责任公司",1.38,null,"超过评"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","醋酸钠林格葡萄糖注射液","500ml",1,"袋","扬子江药业集团上海海尼药业有限公司","扬子江药业集团上海海尼药业有限公司",130.2,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","氯化钾注射液","10ml:1.5g",1,"支","广东星昊药业有限公司","广州合和医药有限公司",1.3,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用尼可地尔","12mg",1,"盒","常州四药制药有限公司","常州四药制药有限公司",16.28,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用尼可地尔","12mg",1,"支","天津天士力之骄药业有限公司","天津天士力之骄药业有限公司",154,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用尼可地尔","48mg",1,"支","天津天士力之骄药业有限公司","天津天士力之骄药业有限公司",445.06,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","马来酸依那普利片","10mg",16,"盒","上海寿如松药业泌阳制药有限公司","上海寿如松药业泌阳制药有限公司",6.92,null,"项目申报错误"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","硫酸阿米卡星注射液","2ml:0.2g(20万单位)",1,"支","宜昌人福药业有限责任公司","宜昌人福药业有限责任公司",0.9,"过评","超同组最低价"]
["国采第十批同通用名(2025年10月份)-集采剂型-不限","哌柏西利胶囊","100mg",21,"瓶","重庆西南制药二厂有限责任公司","江西半边天药业有限公司",2512.05,"过评","超同组最低价"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","75mg(按C₁₆H₁₆ClNO₂S计)",14,"盒","四川鲁徽制药有限责任公司","四川鲁徽制药有限责任公司",30.03,"过评","项目申报错误"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","门冬氨酸钾注射液","10ml:门冬氨酸钾1.712g(按C₄H₆KNO₄计)",1,"支","广东星昊药业有限公司","广州合和医药有限公司",41,"过评","超同组最低价"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","阿托伐他汀钙片","按C₃₃H₃₅FN₂O₅计10mg",14,"盒","四川鲁徽制药有限责任公司","四川鲁徽制药有限责任公司",26.35,"过评","项目申报错误"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","阿托伐他汀钙片","按C₃₃H₃₅FN₂O₅计20mg",14,"盒","四川鲁徽制药有限责任公司","四川鲁徽制药有限责任公司",44.79,"过评","项目申报错误"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","1.0g(按C₁₃H₁₃N₅O₅S₂计)",1,"瓶","海南通用三洋药业有限公司","广州合和医药有限公司",11.91,"过评","项目申报错误"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","0.5mg",50,"盒","海南合瑞制药股份有限公司","海南合瑞制药股份有限公司",420.92,"过评","超同组最低价"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","1mg",50,"盒","海南合瑞制药股份有限公司","海南合瑞制药股份有限公司",715.58,"过评","超同组最低价"]
["2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","依托咪酯中/长链脂肪乳注射液","10ml:20mg",1,"支","扬子江药业集团有限公司","扬子江药业集团有限公司",33.6,"过评","超同组最低价"]
["湖北中成药第二期集采通用名(2025年10月份)-集采剂型-不限","银杏达莫注射液","10ml",1,"支","山西普德药业有限公司","山西普德药业有限公司",13.15,null,"需上传3省挂网截图"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","维生素B₆注射液","1ml:0.1g",1,"支","裕松源药业有限公司","裕松源药业有限公司",4.8,"过评","超未过评2倍"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","维生素K₁注射液","0.2ml:2mg",1,"支","海南倍特药业有限公司","海南倍特药业有限公司",15,"过评","超未过评2倍"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","复方醋酸钠林格注射液","250ml",1,"袋","浙江医药股份有限公司新昌制药厂","浙江医药股份有限公司新昌制药厂",58.24,"过评","超同组最低价"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","倍他米松磷酸钠注射液","1ml∶4mg(按C₂₂H₂₉FO₅计)",1,"支","津药和平(天津)制药有限公司","湖北民康药业集团有限公司",16.25,"过评","超同组最低价"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","倍他米松磷酸钠注射液","0.5ml:2mg(按C₂₂H₂₉FO₅计)",1,"支","新乡市常乐制药有限责任公司","江苏神龙药业有限公司",15.95,"过评","超同组最低价"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","1.0g(按C13H13N5O5S2计)",1,"瓶","山东润泽制药有限公司","山东润泽制药有限公司",9.74,"过评","项目申报错误"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","2.0g(按C13H13N5O5S2计)",1,"瓶","山东润泽制药有限公司","山东润泽制药有限公司",16.56,"过评","项目申报错误"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","0.5g(按C13H13N5O5S2计)",1,"瓶","山东润泽制药有限公司","山东润泽制药有限公司",5.73,"过评","项目申报错误"]
["2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","磺胺嘧啶钠注射液","2ml:0.4g",1,"支","甘肃兰药药业有限公司","甘肃兰药药业有限公司",23.95,null,"超同组最低价"]
["江西干扰素联盟集采同通用名(2025年10月份)-集采剂型-不限","糠酸莫米松乳膏","16g:(0.1%)",1,"盒","武汉诺安药业有限公司","武汉诺安药业有限公司",35.97,null,"项目申报错误"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","兰索拉唑肠溶胶囊","30mg",14,"盒","北京福元医药股份有限公司","北京福元医药股份有限公司",80.26,"过评","超未过评2倍"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","兰索拉唑肠溶胶囊","30mg",28,"盒","北京福元医药股份有限公司","北京福元医药股份有限公司",156.5,"过评","超未过评2倍"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","1mg",100,"瓶","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司",1353.2,"过评","项目申报错误"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","0.5mg",100,"瓶","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司",796,"过评","项目申报错误"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司缓释胶囊","0.5mg",50,"盒","杭州中美华东制药有限公司","杭州中美华东制药有限公司",600,"过评","超同组最低价"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司缓释胶囊","1mg",50,"盒","杭州中美华东制药有限公司","杭州中美华东制药有限公司",1020,"过评","超同组最低价"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","洛索洛芬钠凝胶贴膏","每贴(14cm×10cm)含膏体10g,含洛索洛芬钠100mg(按C₁₅H₁₇NaO₃计)",3,"盒","江苏万高药业股份有限公司","江苏万高药业股份有限公司",57.86,"过评","超同组最低价"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","洛索洛芬钠凝胶贴膏","每贴(14cm×10cm)含膏体10g,含洛索洛芬钠100mg(按C₁₅H₁₇NaO₃计)",5,"盒","江苏万高药业股份有限公司","江苏万高药业股份有限公司",96.43,"过评","超同组最低价"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","盐酸倍他司汀注射液","2ml:10mg",1,"支","河南普瑞药业有限公司","河南普瑞药业有限公司",11.6,null,"超同组最低价"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","盐酸倍他司汀注射液","2ml:10mg",1,"支","山东辉成药业有限公司","山东辉成药业有限公司",11.63,null,"超同组最低价"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","吸入用丙酸倍氯米松混悬液","2ml:0.8mg",20,"盒","江西艾施特制药有限公司","江西艾施特制药有限公司",189.2,"过评","项目申报错误"]
["京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","复方丹参片","每片重0.32g(相当于饮片0.6g)",60,"盒","兰州佛慈制药股份有限公司","兰州佛慈制药股份有限公司",6.86,null,"项目申报错误"]
["京津冀(天津)集采同通用名(2025年10月份)-集采剂型-不限","托拉塞米片","5mg",15,"盒","太极集团四川太极制药有限公司","重庆仁泽医药科技有限公司",18.15,"过评","同厂家不符合差比"]
["京津冀(天津)集采同通用名(2025年10月份)-集采剂型-不限","依托咪酯中/长链脂肪乳注射液","10ml:20mg",1,"支","重庆药友制药有限责任公司","重庆药友制药有限责任公司",36.7,"过评","超同组最低价"]
["京津冀(天津)集采同通用名(2025年10月份)-集采剂型-不限","天麻素注射液","2ml:200mg",1,"支","哈尔滨三联药业股份有限公司","哈尔滨圣泰生物制药有限公司",37.5,null,"超同组最低价"]
["京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","0.75g(C25H27N9O8S20.5g与C8H11NO5S0.25g)",1,"瓶","山东润泽制药有限公司","山东润泽制药有限公司",19.91,"过评","超同组最低价"]
["京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","1.5g(C25H27N9O8S21.0g与C8H11NO5S0.5g)",1,"瓶","山东润泽制药有限公司","山东润泽制药有限公司",33.86,"过评","超同组最低价"]
["京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","2.25g(C25H27N9O8S21.5g与C8H11NO5S0.75g)",1,"瓶","山东润泽制药有限公司","山东润泽制药有限公司",46.18,"过评","超同组最低价"]
["京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","3.0g(C25H27N9O8S22.0g与C8H11NO5S1.0g)",1,"瓶","山东润泽制药有限公司","山东润泽制药有限公司",57.56,"过评","超同组最低价"]
["京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","0.5g(按C₁₃H₁₃N₅O₅S₂计)",1,"瓶","重庆吉斯瑞制药有限责任公司","重庆吉斯瑞制药有限责任公司",11.4,"过评","超同组最低价"]
["京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用氯诺昔康","8mg(每瓶实装8.6mg)",1,"瓶","成都通德药业有限公司","成都米子生物医药科技有限公司",9.66,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","乌拉地尔缓释胶囊","30mg",10,"盒","石家庄四药有限公司","石家庄四药有限公司",81,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","盐酸尼卡地平氯化钠注射液","200ml:盐酸尼卡地平20mg与氯化钠1.72g",1,"袋","石家庄四药有限公司","石家庄四药有限公司",77.84,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","夫西地酸乳膏","2%(15g:0.3g,按C₃₁H₄₈O₆计)",1,"盒","重庆华邦制药有限公司","重庆华邦制药有限公司",28.6,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","拉莫三嗪分散片","25mg",56,"盒","西安远大德天药业股份有限公司","西安远大德天药业股份有限公司",109.78,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","劳拉西泮片","1mg",20,"瓶","Atlantic Laboratories Corporation, Ltd.","海南大西洋制药厂有限公司",20.68,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","阿戈美拉汀片","25mg",14,"盒","重庆药友制药有限责任公司","湖南洞庭药业股份有限公司",127.79,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","阿戈美拉汀片","25mg",14,"盒","石家庄龙泽制药股份有限公司","北京海步医药科技有限公司",119,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","注射用盐酸倍他司汀","20mg",1,"支","国药集团国瑞药业有限公司","国药集团国瑞药业有限公司",11.07,null,"超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","富马酸福莫特罗吸入溶液","2ml:20µg[按C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计)]",5,"盒","罗欣安若维他药业(成都)有限公司","成都海德康药业有限公司",90,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","富马酸福莫特罗吸入溶液","2ml:20µg[按C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计)]",10,"盒","罗欣安若维他药业(成都)有限公司","成都海德康药业有限公司",180,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","氨溴特罗口服溶液","100ml:盐酸氨溴索150mg与盐酸克仑特罗100µg",1,"盒","湖南九典制药股份有限公司","江西仁齐制药有限公司",29.8,"过评","超同组最低价"]
["2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","地氯雷他定口服溶液","100ml:50mg",1,"盒","山东简道制药有限公司","山东简道制药有限公司",86,"过评","超同组最低价"]

{"sheet":"原文件","index":1,"n_rows":121,"n_cols":13,"rows_kept":121,"merged":[[0,0,0,12]],"flags":["formulas_cached_only"]}
["不符合挂网条件药品表"]
["药品统一编码","目录名称","产品名称","剂型","规格","转换比","最小包装单位","包装材质","生产企业","投标企业","报价","质量层次","不符合原因"]
["XB01ACL190A001010200153","国采第一批同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","片剂(薄膜衣片)","75mg(按C₁₆H₁₆ClNO₂S计)",14,"盒","双铝泡罩包装","北京四环制药有限公司,新华制药(高密)有限公司","山东新华制药股份有限公司",28.56,"过评","超同组最低价"]
["XB01ACL190A001010400153","国采第一批同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","片剂(薄膜衣片)","75mg(按C₁₆H₁₆ClNO₂S计)",28,"盒","双铝泡罩包装","北京四环制药有限公司,新华制药(高密)有限公司","山东新华制药股份有限公司",55.69,"过评","超同组最低价"]
["XB01ACL190A001010400430","国采第一批同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","薄膜衣片","75mg(按C₁₆H₁₆ClNO₂S计)",28,"盒","药用铝箔和聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片泡罩包装","国药集团致君(深圳)坪山制药有限公司","国药集团致君(深圳)制药有限公司",35.14,"过评","超同组最低价"]
["XJ05AFE013A001010107011","国采第一批同通用名(2025年10月份)-集采剂型-不限","恩替卡韦片","片剂","0.5mg",30,"盒","口服固体药用高密度聚乙烯瓶","郑州泰丰制药有限公司","佑华医药科技有限公司",8.16,"过评","超同组最低价"]
["XR03DCM082A001010583521","国采第一批同通用名(2025年10月份)-集采剂型-不限","孟鲁司特钠片","片剂","10mg(按C₃₅H₃₆ClNO₃S计)",10,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","浙江诺得药业有限公司","浙江诺得药业有限公司",24.98,"过评","超同组最低价"]
["XR03DCM082A001013583521","国采第一批同通用名(2025年10月份)-集采剂型-不限","孟鲁司特钠片","片剂","10mg(按C₃₅H₃₆ClNO₃S计)",30,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","浙江诺得药业有限公司","浙江诺得药业有限公司",71.99,"过评","超同组最低价"]
["XC01EBQ102A010010107011","国采第二批同通用名(2025年10月份)-集采剂型-不限","盐酸曲美他嗪缓释片","片剂","35mg",30,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","郑州泰丰制药有限公司","佑华医药科技有限公司",13.74,"过评","超同组最低价"]
["XJ01FAA051A001030179335","国采第二批同通用名(2025年10月份)-集采剂型-不限","阿奇霉素片","片剂","500mg",3,"盒","PVC 铝箔泡罩","Pliva Croatia Ltd.","海南华蓝医药健康产业有限公司",68,"原研/参比","超原研"]
["XP01ABJ070A001010103059","国采第二批同通用名(2025年10月份)-集采剂型-不限","甲硝唑片","片剂","0.2g",100,"瓶","口服固体药用高密度聚乙烯瓶包装","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司",7.1,"过评","超同组最低价"]
["XA02AHT018A001010104363","国采第三批同通用名(2025年10月份)-集采剂型-不限","碳酸氢钠片","片剂","0.5g",100,"瓶","塑瓶","安徽永生堂药业有限责任公司","安徽永生堂药业有限责任公司",8,null,"超同组最低价"]
["XB01AFA281A001010183063","国采第三批同通用名(2025年10月份)-集采剂型-不限","阿哌沙班片","片剂","2.5mg",20,"盒","聚氯乙烯固体药用硬片及药品包装用铝箔包装","迪沙药业集团有限公司","迪沙药业集团有限公司",43.38,"过评","超同组最低价"]
["XJ01MAM134B002010284003","国采第三批同通用名(2025年10月份)-集采剂型-不限","盐酸莫西沙星氯化钠注射液","注射剂","250ml∶盐酸莫西沙星(按C₂₁H₂₄FN₃O₄计)0.4g与氯化钠2.0g",1,"盒","中硼硅玻璃输液瓶","东莞市普济药业有限公司","安徽康融药业有限公司",28,"过评","超同组最低价"]
["XM04AAF670A001010184519","国采第三批同通用名(2025年10月份)-集采剂型-不限","非布司他片","片剂(薄膜衣片)","20mg",14,"盒","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药品包装用铝箔包装","华益药业科技(安徽)有限公司","昆明龙津药业股份有限公司",35.8,"过评","超同组最低价"]
["XM04AAF670A001020184519","国采第三批同通用名(2025年10月份)-集采剂型-不限","非布司他片","片剂","40mg",14,"盒","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药品包装用铝箔包装","华益药业科技(安徽)有限公司","昆明龙津药业股份有限公司",63,"过评","超同组最低价"]
["XS01AEZ074G010010103305","国采第三批同通用名(2025年10月份)-集采剂型-不限","盐酸左氧氟沙星滴眼液","滴眼液","0.3%(按C18H20FN3O4计),5ml/支",1,"盒","棕色低密度聚乙烯药用滴眼剂瓶","长春迪瑞制药有限公司","长春迪瑞制药有限公司",3.63,null,"超过评"]
["XA02BCA081E005010101525","国采第四批同通用名(2025年10月份)-集采剂型-不限","艾司奥美拉唑镁肠溶胶囊","胶囊剂","20mg(按C₁₇H₁₉N₃O₃S计)",30,"盒","口服固体药用高密度聚乙烯瓶包装(内置药用固体纸袋装硅胶干燥剂)","江苏中邦制药有限公司","江苏中邦制药有限公司",108,"过评","超同组最低价"]
["XA02BCA081E005020101525","国采第四批同通用名(2025年10月份)-集采剂型-不限","艾司奥美拉唑镁肠溶胶囊","胶囊剂","40mg(按C₁₇H₁₉N₃O₃S计)",30,"盒","口服固体药用高密度聚乙烯瓶包装(内置药用固体纸袋装硅胶干燥剂)","江苏中邦制药有限公司","江苏中邦制药有限公司",183.6,"过评","超同组最低价"]
["XC09DBX206A001010101874","国采第四批同通用名(2025年10月份)-集采剂型-不限","缬沙坦氨氯地平片(Ⅰ)","片剂(薄膜衣片)","每片含缬沙坦80mg,氨氯地平5mg",7,"盒","聚氯乙烯固体药用硬片和药品包装用铝箔,外套聚酯/铝/聚乙烯药用复合膜","湖北午时药业股份有限公司","湖北午时药业股份有限公司",27.02,"过评","超同组最低价"]
["XJ01MAZ074A001010101874","国采第四批同通用名(2025年10月份)-集采剂型-不限","甲磺酸左氧氟沙星片","片剂","0.1g",12,"盒","聚氯乙烯固体药用硬片、药品包装用铝箔","湖北午时药业股份有限公司","湖北午时药业股份有限公司",6.8,null,"超过评"]
["XN02BGP112E001010104606","国采第四批同通用名(2025年10月份)-集采剂型-不限","普瑞巴林胶囊","胶囊剂","75mg",8,"盒","聚氯乙烯固体药用硬片和药品包装用铝箔包装","浙江昂利康制药股份有限公司","浙江昂利康制药股份有限公司",18.88,"过评","超同组最低价"]
["XS01GXA210G010010100547","国采第四批同通用名(2025年10月份)-集采剂型-不限","盐酸奥洛他定滴眼液","眼用制剂","0.2%(2.5ml:5mg,按C₂₁H₂₃NO₃计)",1,"盒","白色低密度聚乙烯滴瓶,带有低密度聚乙烯内塞和聚丙烯瓶盖","深圳万和制药有限公司","深圳万和制药有限公司",62.8,"过评","超同组最低价"]
["XA02BCA081B001020204021","国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用艾司奥美拉唑钠","注射剂","40mg(按C₁₇H₁₉N₃O₃S计)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞","齐鲁制药(海南)有限公司","齐鲁制药有限公司",3.59,"过评","超同组最低价"]
["XJ01DCT070B001030104651","国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用头孢呋辛钠","注射剂","1.5g",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚酯膜卤化丁基橡胶塞","浙江惠迪森药业有限公司","浙江惠迪森药业有限公司",13.46,"过评","超同组最低价"]
["XJ01DCT070B001040104651","国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用头孢呋辛钠","注射剂","0.75g",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚酯膜卤化丁基橡胶塞","浙江惠迪森药业有限公司","浙江惠迪森药业有限公司",7.92,"过评","超同组最低价"]
["XJ01DDT094B001020105755","国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用头孢他啶","注射剂","1.0g(按C22H22N6O7S2计算)",1,"盒","管制抗生素瓶装","海口奇力制药股份有限公司","海口奇力制药股份有限公司",8.37,"过评","超同组最低价"]
["XJ01MAZ074B002010200219","国采第五批同通用名(2025年10月份)-集采剂型-不限","左氧氟沙星注射液","注射剂","20ml:500mg",1,"支","中硼硅玻璃安瓿","山东罗欣药业集团股份有限公司","国仁健康制药(北京)有限公司",27.3,"过评","超同组最低价"]
["XJ01MAZ083B002020109938","国采第五批同通用名(2025年10月份)-集采剂型-不限","左氧氟沙星氯化钠注射液","注射剂","100ml:左氧氟沙星(按C₁₈H₂₀FN₃O₄计)0.5g与氯化钠0.9g",1,"袋","五层共挤输液用袋","广东大翔制药有限公司","广东大翔制药有限公司",9.9,"过评","超同组最低价"]
["XL01AAB230B001010100549","国采第五批同通用名(2025年10月份)-集采剂型-不限","注射用盐酸苯达莫司汀","注射剂","100mg(按C₁₆H₂₁Cl₂N₃O₂•HCl计)",1,"盒","中性硼硅玻璃管制镀聚二甲基硅氧烷膜注射剂瓶,注射制剂用溴化丁基橡胶塞和抗生素瓶用铝塑组合盖","深圳万乐药业有限公司","深圳万乐药业有限公司",1080,"过评","超同组最低价"]
["XN05AXA028A001010104917","国采第五批同通用名(2025年10月份)-集采剂型-不限","阿立哌唑片","片剂","5mg",28,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片,药用铝箔","重庆药友制药有限责任公司","湖南洞庭药业股份有限公司",44.34,"过评","超同组最低价"]
["XR03BBY139L019010184315","国采第五批同通用名(2025年10月份)-集采剂型-不限","吸入用异丙托溴铵溶液","吸入制剂","2ml:0.5mg(按C₂₀H₃₀BrNO₃计)",5,"盒","聚丙烯安瓿＋聚酯/铝/聚乙烯药品包装用复合膜、袋","山东华鲁制药有限公司","佑华医药科技有限公司",18.4,"过评","超同组最低价"]
["XS01AEM122G010020102733","国采第五批同通用名(2025年10月份)-集采剂型-不限","盐酸莫西沙星滴眼液","眼用制剂","0.5%(0.4ml:2mg,按C₂₁H₂₄FN₃O₄计)",5,"盒","低密度聚乙烯药用单剂量滴眼剂瓶,外套聚酯/铝/聚乙烯药用复合膜袋。","石家庄格瑞药业有限公司","石家庄格瑞药业有限公司",13.5,"过评","超同组最低价"]
["XC01BBL054B002040201866","国采第七批同通用名(2025年10月份)-集采剂型-不限","盐酸利多卡因注射液","注射剂","5ml:0.1g",1,"支","中硼硅玻璃安瓶","湖北津药药业股份有限公司","湖北津药药业股份有限公司",3.82,"过评","超同组最低价"]
["XC10AXY097A001010184548","国采第七批同通用名(2025年10月份)-集采剂型-不限","依折麦布片","片剂","10mg",10,"盒","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","昆明龙津药业股份有限公司","云南龙津康佑生物医药有限公司",26.2,"过评","超同组最低价"]
["XJ01DCT078B001010104339","国采第七批同通用名(2025年10月份)-集采剂型-不限","注射用头孢米诺钠","注射剂","0.5g",1,"瓶","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用溴化丁基橡胶塞","安徽省先锋制药有限公司","安徽省先锋制药有限公司",15.95,"过评","超同组最低价"]
["XJ01DCT078B001020104339","国采第七批同通用名(2025年10月份)-集采剂型-不限","注射用头孢米诺钠","注射剂","1.0g",1,"瓶","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用溴化丁基橡胶塞","安徽省先锋制药有限公司","安徽省先锋制药有限公司",27.11,"过评","超同组最低价"]
["XN03AXL371A001010200698","国采第七批同通用名(2025年10月份)-集采剂型-不限","拉考沙胺片","片剂","50mg",56,"盒","聚氯乙烯固体药用硬片、药用铝箔包装。","上海理想制药有限公司","上海理想制药有限公司",152.76,"过评","超同组最低价"]
["XN03AXL371A001020100698","国采第七批同通用名(2025年10月份)-集采剂型-不限","拉考沙胺片","片剂","100mg",56,"盒","聚氯乙烯固体药用硬片、药用铝箔包装。","上海理想制药有限公司","上海理想制药有限公司",259.69,"过评","超同组最低价"]
["XN05AEL375A001010101066","国采第七批同通用名(2025年10月份)-集采剂型-不限","盐酸鲁拉西酮片","片剂(薄膜衣片)","按C₂₈H₃₆N₄O₂S·HCl计:40mg",30,"瓶","口服固体药用高密度聚乙烯瓶","重庆药友制药有限责任公司","重庆药友制药有限责任公司",117,"过评","超同组最低价"]
["XC08CXA188A001010705024","国采第八批同通用名(2025年10月份)-集采剂型-不限","氨氯地平阿托伐他汀钙片","片剂","5mg/10mg(以氨氯地平/阿托伐他汀计)",15,"盒","药品包装用铝箔和聚氯乙烯固体药用硬片","湖南威特制药股份有限公司","湖南威特制药股份有限公司",37.65,"过评","超同组最低价"]
["XJ01CRP018B001010105755","国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用哌拉西林钠他唑巴坦钠","注射剂","1.125g(含哌拉西林1.0g,他唑巴坦0.125g)",1,"瓶","管制抗生素瓶装","海口奇力制药股份有限公司","海口奇力制药股份有限公司",6.43,"过评","超同组最低价"]
["XJ01CRP018B001020105755","国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用哌拉西林钠他唑巴坦钠","注射剂","2.25g(含哌拉西林2.0g,他唑巴坦0.25g)",1,"瓶","管制抗生素瓶装","海口奇力制药股份有限公司","海口奇力制药股份有限公司",10.93,"过评","超同组最低价"]
["XJ01CRP018B001030105755","国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用哌拉西林钠他唑巴坦钠","注射剂","4.5g(含哌拉西林4.0g,他唑巴坦0.5g)",1,"盒","管制抗生素瓶","海口奇力制药股份有限公司","海口奇力制药股份有限公司",18.58,"过评","超同组最低价"]
["XJ01DDT068N001010382974","国采第八批同通用名(2025年10月份)-集采剂型-不限","头孢地尼颗粒","颗粒剂","50mg",6,"盒","聚酯/铝/聚乙烯药用复合膜袋装","四川合信药业有限责任公司","重庆吉斯瑞制药有限责任公司",60,"过评","超同组最低价"]
["XJ01DHB084B001010183832","国采第八批同通用名(2025年10月份)-集采剂型-不限","注射用比阿培南","注射剂","0.3g",1,"盒","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜氯化丁基橡胶塞。","山东罗欣药业集团股份有限公司","江苏睿实生物科技有限公司",72,"过评","超同组最低价"]
["XJ01XDJ185B002010302968","国采第八批同通用名(2025年10月份)-集采剂型-不限","甲硝唑氯化钠注射液","注射液","100ml:甲硝唑0.5g与氯化钠0.74g",1,"袋","三层共挤输液用膜、塑料输液容器用聚丙烯接口、塑料输液容器用聚丙烯组合盖(拉环式)","广东大翔制药有限公司","广东大翔制药有限公司",5.78,"过评","超同组最低价"]
["XJ05AHA218X006010184219","国采第八批同通用名(2025年10月份)-集采剂型-不限","磷酸奥司他韦干混悬剂","口服混悬剂","0.36g(按C₁₆H₂₈N₂O₄计)",1,"盒","钠钙玻璃模制药瓶、口服药用聚丙烯压旋盖。","山西同达药业有限公司","山西同达药业有限公司",59,"过评","超同组最低价"]
["XJ05AHA218X006010384219","国采第八批同通用名(2025年10月份)-集采剂型-不限","磷酸奥司他韦干混悬剂","口服混悬剂","0.36g(按C₁₆H₂₈N₂O₄计)",2,"盒","钠钙玻璃模制药瓶、口服药用聚丙烯压旋盖。","山西同达药业有限公司","山西同达药业有限公司",118,"过评","超同组最低价"]
["XA02BCA349E001010280214","国采第九批同通用名(2025年10月份)-集采剂型-不限","奥美拉唑碳酸氢钠胶囊(Ⅱ)","胶囊剂","每粒含奥美拉唑40mg与碳酸氢钠1100mg",30,"瓶","口服固体药用高密度聚乙烯瓶装","厦门恩成制药有限公司","厦门恩成制药有限公司",34.01,null,"超过评"]
["XA12AAP104B002020102763","国采第九批同通用名(2025年10月份)-集采剂型-不限","葡萄糖酸钙氯化钠注射液","注射剂","100ml:葡萄糖酸钙1g与氯化钠0.8g",1,"袋","三层共挤输液用袋,外加聚酯/真空镀铝聚酯/聚乙烯药用复合膜袋","石家庄四药有限公司","石家庄四药有限公司",5.62,"过评","超同组最低价"]
["XA12CCL146B002010183184","国采第九批同通用名(2025年10月份)-集采剂型-不限","硫酸镁注射液","注射剂","100ml:4g",1,"袋","五层共挤输液用膜制袋,外加聚酯/铝/聚乙烯药品包装用复合膜","山东华鲁制药有限公司","北京柏雅联合药物研究所有限公司",66,"过评","超同组最低价"]
["XC09DBA313A001010184548","国采第九批同通用名(2025年10月份)-集采剂型-不限","奥美沙坦酯氨氯地平片","片剂","每片含奥美沙坦酯20mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)",8,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","昆明龙津药业股份有限公司","云南龙津康佑生物医药有限公司",9.91,"过评","超同组最低价"]
["XG04BEX006A022010184548","国采第九批同通用名(2025年10月份)-集采剂型-不限","枸橼酸西地那非口崩片","片剂","50mg(按C₂₂H₃₀N₆O₄S计)",2,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔。","昆明龙津药业股份有限公司","云南龙津康佑生物医药有限公司",36,"过评","超同组最低价"]
["XN05AXA028X001010184209","国采第九批同通用名(2025年10月份)-集采剂型-不限","阿立哌唑口服溶液","口服溶液剂","50ml:50mg",1,"盒","口服液体药用高密度聚乙烯瓶","浙江北生药业汉生制药有限公司","西洲医药科技(浙江)有限公司",82,"过评","超同组最低价"]
["XS01XAD324G010010100547","国采第九批同通用名(2025年10月份)-集采剂型-不限","地夸磷索钠滴眼液","眼用制剂","3%(5ml:150mg)",1,"盒","低密度聚乙烯药用滴眼剂瓶","深圳万和制药有限公司","深圳万和制药有限公司",56.3,"过评","超同组最低价"]
["XS01XAD324G010010102733","国采第九批同通用名(2025年10月份)-集采剂型-不限","地夸磷索钠滴眼液","眼用制剂","3%(5ml:150mg)",1,"盒","低密度聚乙烯药用滴眼剂瓶","石家庄格瑞药业有限公司","石家庄格瑞药业有限公司",49.3,"过评","超同组最低价"]
["XS01XAD324G010020102733","国采第九批同通用名(2025年10月份)-集采剂型-不限","地夸磷索钠滴眼液","眼用制剂","3%(0.4ml:12mg)",10,"盒","低密度聚乙烯药用单剂量滴眼剂瓶","石家庄格瑞药业有限公司","石家庄格瑞药业有限公司",71.31,"过评","超同组最低价"]
["XA02BAL338B001010184568","国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用盐酸罗沙替丁醋酸酯","注射剂","75mg",1,"支","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥用氯化丁基橡胶塞","湖北午时药业股份有限公司","湖北午时药业股份有限公司",145,"过评","超同组最低价"]
["XA10BDX223A001010281012","国采第十批同通用名(2025年10月份)-集采剂型-不限","西格列汀二甲双胍片(Ⅱ)","片剂(薄膜衣片)","每片含磷酸西格列汀50mg(以C₁₆H₁₅F₆N₅O计)和盐酸二甲双胍850mg(以C₄H₁₁N₅•HCl计)",14,"盒","聚氯乙烯固体药用硬片及药用铝箔包装","浙江永太药业有限公司","浙江永太药业有限公司",47.6,"过评","超同组最低价"]
["XB01ACA056A012010101471","国采第十批同通用名(2025年10月份)-集采剂型-不限","阿司匹林肠溶片","片剂","25mg",100,"瓶","塑料瓶","平光制药股份有限公司,江苏平光制药有限责任公司","江苏平光制药有限责任公司",1.38,null,"超过评"]
["XB05BBC177B002010100841","国采第十批同通用名(2025年10月份)-集采剂型-不限","醋酸钠林格葡萄糖注射液","注射液","500ml",1,"袋","五层共挤输液用袋包装","扬子江药业集团上海海尼药业有限公司","扬子江药业集团上海海尼药业有限公司",130.2,"过评","超同组最低价"]
["XB05XAL208B002010185013","国采第十批同通用名(2025年10月份)-集采剂型-不限","氯化钾注射液","注射剂","10ml:1.5g",1,"支","聚丙烯安瓿","广东星昊药业有限公司","广州合和医药有限公司",1.3,"过评","超同组最低价"]
["XC01DXN039B001010101389","国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用尼可地尔","注射剂","12mg",1,"盒","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖","常州四药制药有限公司","常州四药制药有限公司",16.28,"过评","超同组最低价"]
["XC01DXN039B001010300940","国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用尼可地尔","注射剂","12mg",1,"支","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装。","天津天士力之骄药业有限公司","天津天士力之骄药业有限公司",154,"过评","超同组最低价"]
["XC01DXN039B001020100940","国采第十批同通用名(2025年10月份)-集采剂型-不限","注射用尼可地尔","注射剂","48mg",1,"支","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装。","天津天士力之骄药业有限公司","天津天士力之骄药业有限公司",445.06,"过评","超同组最低价"]
["XC09AAY074A001010103165","国采第十批同通用名(2025年10月份)-集采剂型-不限","马来酸依那普利片","片剂","10mg",16,"盒","复合膜","上海寿如松药业泌阳制药有限公司","上海寿如松药业泌阳制药有限公司",6.92,null,"项目申报错误"]
["XJ01GBA034B002010202000","国采第十批同通用名(2025年10月份)-集采剂型-不限","硫酸阿米卡星注射液","注射剂","2ml:0.2g(20万单位)",1,"支","中硼硅玻璃安瓿","宜昌人福药业有限责任公司","宜昌人福药业有限责任公司",0.9,"过评","超同组最低价"]
["XL01EFP135E001010105258","国采第十批同通用名(2025年10月份)-集采剂型-不限","哌柏西利胶囊","胶囊剂","100mg",21,"瓶","带聚丙烯(PP)盖的高密度聚乙烯(HDPE)瓶包装","重庆西南制药二厂有限责任公司","江西半边天药业有限公司",2512.05,"过评","超同组最低价"]
["XB01ACL190A001010283572","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","硫酸氢氯吡格雷片","片剂(薄膜衣片)","75mg(按C₁₆H₁₆ClNO₂S计)",14,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","四川鲁徽制药有限责任公司","四川鲁徽制药有限责任公司",30.03,"过评","项目申报错误"]
["XB05XAM073B002010185013","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","门冬氨酸钾注射液","注射剂","10ml:门冬氨酸钾1.712g(按C₄H₆KNO₄计)",1,"支","聚丙烯安瓿包装","广东星昊药业有限公司","广州合和医药有限公司",41,"过评","超同组最低价"]
["XC10AAA067A001010183572","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","阿托伐他汀钙片","片剂(薄膜衣片)","按C₃₃H₃₅FN₂O₅计10mg",14,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","四川鲁徽制药有限责任公司","四川鲁徽制药有限责任公司",26.35,"过评","项目申报错误"]
["XC10AAA067A001020183572","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","阿托伐他汀钙片","片剂(薄膜衣片)","按C₃₃H₃₅FN₂O₅计20mg",14,"盒","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","四川鲁徽制药有限责任公司","四川鲁徽制药有限责任公司",44.79,"过评","项目申报错误"]
["XJ01DDT104B001010185013","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","注射剂","1.0g(按C₁₃H₁₃N₅O₅S₂计)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜溴化丁基橡胶塞(BF1)和抗生素瓶用铝塑组合盖包装","海南通用三洋药业有限公司","广州合和医药有限公司",11.91,"过评","项目申报错误"]
["XL04ADT002E001010105815","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","胶囊剂","0.5mg",50,"盒","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔并加带干燥剂,包装在聚酯/铝/聚乙烯药用复合袋内","海南合瑞制药股份有限公司","海南合瑞制药股份有限公司",420.92,"过评","超同组最低价"]
["XL04ADT002E001020205815","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","胶囊剂","1mg",50,"盒","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔并加带干燥剂,包装在聚酯/铝/聚乙烯药用复合袋内","海南合瑞制药股份有限公司","海南合瑞制药股份有限公司",715.58,"过评","超同组最低价"]
["XN01AXY337B002010101749","2022年河北集中带量采购同通用名(2025年10月份)-集采剂型-不限","依托咪酯中/长链脂肪乳注射液","注射剂","10ml:20mg",1,"支","中硼硅玻璃安瓿","扬子江药业集团有限公司","扬子江药业集团有限公司",33.6,"过评","超同组最低价"]
["XC02CXY165B002040102918","湖北中成药第二期集采通用名(2025年10月份)-集采剂型-不限","银杏达莫注射液","注射液","10ml",1,"支","安瓿","山西普德药业有限公司","山西普德药业有限公司",13.15,null,"需上传3省挂网截图"]
["XA11HAW041B002010203163","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","维生素B₆注射液","注射剂","1ml:0.1g",1,"支","中硼硅玻璃安瓿","裕松源药业有限公司","裕松源药业有限公司",4.8,"过评","超未过评2倍"]
["XB02BAW055B002010105791","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","维生素K₁注射液","注射液","0.2ml:2mg",1,"支","中硼硅玻璃安瓿(棕色)","海南倍特药业有限公司","海南倍特药业有限公司",15,"过评","超未过评2倍"]
["XB05BBF690B002010107968","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","复方醋酸钠林格注射液","注射剂","250ml",1,"袋","三层共挤输液用袋包装","浙江医药股份有限公司新昌制药厂","浙江医药股份有限公司新昌制药厂",58.24,"过评","超同组最低价"]
["XH02ABB044B002010184564","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","倍他米松磷酸钠注射液","注射剂","1ml∶4mg(按C₂₂H₂₉FO₅计)",1,"支","中硼硅玻璃安瓿","津药和平(天津)制药有限公司","湖北民康药业集团有限公司",16.25,"过评","超同组最低价"]
["XH02ABB044B002020101478","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","倍他米松磷酸钠注射液","注射剂","0.5ml:2mg(按C₂₂H₂₉FO₅计)",1,"支","中硼硅玻璃安瓿","新乡市常乐制药有限责任公司","江苏神龙药业有限公司",15.95,"过评","超同组最低价"]
["XJ01DDT104B001010100609","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","注射剂","1.0g(按C13H13N5O5S2计)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞","山东润泽制药有限公司","山东润泽制药有限公司",9.74,"过评","项目申报错误"]
["XJ01DDT104B001020100609","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","注射剂","2.0g(按C13H13N5O5S2计)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞","山东润泽制药有限公司","山东润泽制药有限公司",16.56,"过评","项目申报错误"]
["XJ01DDT104B001030100609","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","注射剂","0.5g(按C13H13N5O5S2计)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞","山东润泽制药有限公司","山东润泽制药有限公司",5.73,"过评","项目申报错误"]
["XJ01ECH068B002010105863","2023年河北省集中带量采购同通用名(2025年10月份)-集采剂型-不限","磺胺嘧啶钠注射液","注射液","2ml:0.4g",1,"支","安瓿","甘肃兰药药业有限公司","甘肃兰药药业有限公司",23.95,null,"超同组最低价"]
["XD07ACK037F002090101955","江西干扰素联盟集采同通用名(2025年10月份)-集采剂型-不限","糠酸莫米松乳膏","乳膏剂","16g:(0.1%)",1,"盒","铝质药用软膏管包装","武汉诺安药业有限公司","武汉诺安药业有限公司",35.97,null,"项目申报错误"]
["XA02BCL033E005020200177","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","兰索拉唑肠溶胶囊","肠溶胶囊","30mg",14,"盒","聚氯乙烯固体药用硬片和药用铝箔,外加聚酯/铝/聚乙烯药用复合膜、袋包装","北京福元医药股份有限公司","北京福元医药股份有限公司",80.26,"过评","超未过评2倍"]
["XA02BCL033E005020400177","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","兰索拉唑肠溶胶囊","肠溶胶囊","30mg",28,"盒","聚氯乙烯固体药用硬片和药用铝箔,外加聚酯/铝/聚乙烯药用复合膜、袋包装","北京福元医药股份有限公司","北京福元医药股份有限公司",156.5,"过评","超未过评2倍"]
["XL04ADT002E001010185294","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","胶囊剂","1mg",100,"瓶","高密度聚乙烯瓶,带儿童安全盖","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司",1353.2,"过评","项目申报错误"]
["XL04ADT002E001020185294","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司胶囊","胶囊剂","0.5mg",100,"瓶","高密度聚乙烯瓶,带儿童安全盖","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司",796,"过评","项目申报错误"]
["XL04ADT002E003010104520","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司缓释胶囊","胶囊剂","0.5mg",50,"盒","铝塑泡罩式包装并加带干燥剂,外加一层复合膜袋","杭州中美华东制药有限公司","杭州中美华东制药有限公司",600,"过评","超同组最低价"]
["XL04ADT002E003020104520","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","他克莫司缓释胶囊","胶囊剂","1mg",50,"盒","铝塑泡罩式包装并加带干燥剂,外加一层复合膜袋","杭州中美华东制药有限公司","杭州中美华东制药有限公司",1020,"过评","超同组最低价"]
["XM01AEL283V006010301503","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","洛索洛芬钠凝胶贴膏","贴膏剂","每贴(14cm×10cm)含膏体10g,含洛索洛芬钠100mg(按C₁₅H₁₇NaO₃计)",3,"盒","纸/铝/聚乙烯药品包装用复合膜、袋","江苏万高药业股份有限公司","江苏万高药业股份有限公司",57.86,"过评","超同组最低价"]
["XM01AEL283V006010401503","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","洛索洛芬钠凝胶贴膏","贴膏剂","每贴(14cm×10cm)含膏体10g,含洛索洛芬钠100mg(按C₁₅H₁₇NaO₃计)",5,"盒","纸/铝/聚乙烯药品包装用复合膜、袋","江苏万高药业股份有限公司","江苏万高药业股份有限公司",96.43,"过评","超同组最低价"]
["XN07CAB046B002010101088","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","盐酸倍他司汀注射液","注射液","2ml:10mg",1,"支","玻璃安瓿瓶","河南普瑞药业有限公司","河南普瑞药业有限公司",11.6,null,"超同组最低价"]
["XN07CAB046B002010103987","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","盐酸倍他司汀注射液","注射液","2ml:10mg",1,"支","药用玻璃安瓿装","山东辉成药业有限公司","山东辉成药业有限公司",11.63,null,"超同组最低价"]
["XR01ADB041L023010183755","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","吸入用丙酸倍氯米松混悬液","吸入制剂","2ml:0.8mg",20,"盒","内包装为雾化吸入液体用低密度聚乙烯安瓿,外加聚酯/铝/聚乙烯药用复合膜、袋","江西艾施特制药有限公司","江西艾施特制药有限公司",189.2,"过评","项目申报错误"]
["ZA12BAF0354010105892","京津冀“3+N”联动和集采同通用名(2025年10月份)-集采剂型-不限","复方丹参片","薄膜衣片","每片重0.32g(相当于饮片0.6g)",60,"盒","口服固体药用高密度聚乙烯瓶","兰州佛慈制药股份有限公司","兰州佛慈制药股份有限公司",6.86,null,"项目申报错误"]
["XC03CAT115A001010284681","京津冀(天津)集采同通用名(2025年10月份)-集采剂型-不限","托拉塞米片","片剂","5mg",15,"盒","聚氯乙烯固体药用硬片与药用铝箔","太极集团四川太极制药有限公司","重庆仁泽医药科技有限公司",18.15,"过评","同厂家不符合差比"]
["XN01AXY337B002010101066","京津冀(天津)集采同通用名(2025年10月份)-集采剂型-不限","依托咪酯中/长链脂肪乳注射液","注射液","10ml:20mg",1,"支","中硼硅玻璃安瓿","重庆药友制药有限责任公司","重庆药友制药有限责任公司",36.7,"过评","超同组最低价"]
["XN07XXT050B002010103665","京津冀(天津)集采同通用名(2025年10月份)-集采剂型-不限","天麻素注射液","注射剂","2ml:200mg",1,"支","安瓿","哈尔滨三联药业股份有限公司","哈尔滨圣泰生物制药有限公司",37.5,null,"超同组最低价"]
["XJ01DDT081B013010100609","京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","注射剂","0.75g(C25H27N9O8S20.5g与C8H11NO5S0.25g)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞与抗生素瓶用铝塑组合盖包装","山东润泽制药有限公司","山东润泽制药有限公司",19.91,"过评","超同组最低价"]
["XJ01DDT081B013030100609","京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","注射剂","1.5g(C25H27N9O8S21.0g与C8H11NO5S0.5g)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞与抗生素瓶用铝塑组合盖包装","山东润泽制药有限公司","山东润泽制药有限公司",33.86,"过评","超同组最低价"]
["XJ01DDT081B013050100609","京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","注射剂","2.25g(C25H27N9O8S21.5g与C8H11NO5S0.75g)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞与抗生素瓶用铝塑组合盖包装","山东润泽制药有限公司","山东润泽制药有限公司",46.18,"过评","超同组最低价"]
["XJ01DDT081B013060100609","京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢哌酮钠舒巴坦钠","注射剂","3.0g(C25H27N9O8S22.0g与C8H11NO5S1.0g)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞与抗生素瓶用铝塑组合盖包装","山东润泽制药有限公司","山东润泽制药有限公司",57.56,"过评","超同组最低价"]
["XJ01DDT104B001010182974","京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用头孢唑肟钠","注射剂","0.5g(按C₁₃H₁₃N₅O₅S₂计)",1,"瓶","中硼硅玻璃管制注射剂瓶,注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞","重庆吉斯瑞制药有限责任公司","重庆吉斯瑞制药有限责任公司",11.4,"过评","超同组最低价"]
["XM01ACL238B001010185135","京津冀(北京)集采同通用名(2025年10月份)-集采剂型-不限","注射用氯诺昔康","注射剂","8mg(每瓶实装8.6mg)",1,"瓶","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用卤化丁基胶塞(溴化)、抗生素瓶用铝塑组合盖。","成都通德药业有限公司","成都米子生物医药科技有限公司",9.66,"过评","超同组最低价"]
["XC02CAW069E003010102763","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","乌拉地尔缓释胶囊","胶囊剂","30mg",10,"盒","聚氯乙烯固体药用硬片、药用铝箔","石家庄四药有限公司","石家庄四药有限公司",81,"过评","超同组最低价"]
["XC08CAN078B002010102763","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","盐酸尼卡地平氯化钠注射液","注射剂","200ml:盐酸尼卡地平20mg与氯化钠1.72g",1,"袋","三层共挤输液用袋","石家庄四药有限公司","石家庄四药有限公司",77.84,"过评","超同组最低价"]
["XD06AXF045F002010101003","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","夫西地酸乳膏","乳膏剂","2%(15g:0.3g,按C₃₁H₄₈O₆计)",1,"盒","铝质药用软膏管包装","重庆华邦制药有限公司","重庆华邦制药有限公司",28.6,"过评","超同组最低价"]
["XN03AXL009A006010102469","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","拉莫三嗪分散片","片剂","25mg",56,"盒","铝塑泡罩包装","西安远大德天药业股份有限公司","西安远大德天药业股份有限公司",109.78,"过评","超同组最低价"]
["XN05BAL037A001020178992","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","劳拉西泮片","片剂","1mg",20,"瓶","口服固体药用高密度聚乙烯瓶","Atlantic Laboratories Corporation, Ltd.","海南大西洋制药厂有限公司",20.68,"过评","超同组最低价"]
["XN06AXA268A001010104917","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","阿戈美拉汀片","片剂","25mg",14,"盒","聚氯乙烯固体药用硬片,药用铝箔。","重庆药友制药有限责任公司","湖南洞庭药业股份有限公司",127.79,"过评","超同组最低价"]
["XN06AXA268A001010183603","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","阿戈美拉汀片","片剂(薄膜衣片)","25mg",14,"盒","药用铝箔和聚氯乙烯固体药用硬片","石家庄龙泽制药股份有限公司","北京海步医药科技有限公司",119,"过评","超同组最低价"]
["XN07CAB046B001010104383","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","注射用盐酸倍他司汀","冻干粉针","20mg",1,"支","玻璃管制注射剂瓶","国药集团国瑞药业有限公司","国药集团国瑞药业有限公司",11.07,null,"超同组最低价"]
["XR03ACF104L020010184384","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","富马酸福莫特罗吸入溶液","吸入制剂","2ml:20µg[按C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计)]",5,"盒","本品内包装为低密度聚乙烯安瓿,次级包装为聚酯/铝/聚乙烯药用复合膜、袋。","罗欣安若维他药业(成都)有限公司","成都海德康药业有限公司",90,"过评","超同组最低价"]
["XR03ACF104L020010284384","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","富马酸福莫特罗吸入溶液","吸入制剂","2ml:20µg[按C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计)]",10,"盒","本品内包装为低密度聚乙烯安瓿,次级包装为聚酯/铝/聚乙烯药用复合膜、袋。","罗欣安若维他药业(成都)有限公司","成都海德康药业有限公司",180,"过评","超同组最低价"]
["XR03CCA199X001010105407","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","氨溴特罗口服溶液","口服溶液剂","100ml:盐酸氨溴索150mg与盐酸克仑特罗100µg",1,"盒","口服液体药用聚酯瓶和液体药用塑料瓶盖","湖南九典制药股份有限公司","江西仁齐制药有限公司",29.8,"过评","超同组最低价"]
["XR06AXD078X001010184386","2024年河北牵头京津冀赣化药集采同通用名(2025年10月份)-集采剂型-不限","地氯雷他定口服溶液","口服溶液剂","100ml:50mg",1,"盒","钠钙玻璃模制药瓶、口服液体药用聚丙烯/低密度聚乙烯组合瓶盖","山东简道制药有限公司","山东简道制药有限公司",86,"过评","超同组最低价"]